Aptinyx Inc reported $0 in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Biogen BIIB:US $ 6272.3M 996.9M
Cara Therapeutics CARA:US $ 0 0
Daiichi Sankyo 4568:JP Y 163347M 33148M
Eli Lilly And LLY:US $ 14736.6M 1463M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Halozyme Therapeutics HALO:US $ 785.57M 0.84M
Intra Cellular Therapies ITCI:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 1240.7M 369.78M
Marinus Pharmaceuticals MRNS:US $ 10.97M 10.97M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Novartis NOVN:VX SF 26491M 908M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M